Lai Chung-Jeng, Wu Joe C
IDUN Pharmaceuticals, San Diego, CA 92121, USA.
Assay Drug Dev Technol. 2003 Aug;1(4):527-35. doi: 10.1089/154065803322302781.
A simple diagnostic method for mechanistic analysis of reversible enzyme inhibitors is presented. The method involves simple experimentation to determine how the inhibition by a reversible inhibitor changes in response to the substrate concentration varied in the assay. Four types of inhibitors are categorized based on their kinetic characteristic: (1) competitive or mutually exclusive inhibitors that compete with the substrate for the enzyme; (2) noncompetitive inhibitors that are independent of the substrate for binding to the enzyme; (3) antagonistic inhibitors where the binding affinity of the inhibitor is partially reduced by the substrate binding to the enzyme; and (4) synergistic inhibitors where inhibitor binding is enhanced by substrate binding. An equation was derived for data fitting and subsequent determination of inhibitor binding mode. The method was evaluated in three model enzyme systems, i.e., PK, adenylate kinase, and LDH, with known inhibitors. The method was also used to characterize a large number of unknown Csp3 inhibitors identified from HTS of a compound library consisting of 120,000 distinct chemical entities, a field test that validated the utility of the method. Among 76 Csp3 inhibitors analyzed, 70 were found to be non-mutually exclusive inhibitors, suggesting the existence of an allosteric site(s) in Csp3 for effective inhibition. The implication of this observation is discussed.
本文介绍了一种用于可逆酶抑制剂机制分析的简单诊断方法。该方法涉及简单的实验,以确定可逆抑制剂的抑制作用如何响应测定中变化的底物浓度而改变。根据其动力学特性将抑制剂分为四类:(1)与底物竞争酶的竞争性或互斥性抑制剂;(2)与底物结合无关的非竞争性抑制剂;(3)底物与酶结合会部分降低抑制剂结合亲和力的拮抗性抑制剂;(4)底物结合会增强抑制剂结合的协同性抑制剂。推导了一个用于数据拟合和后续确定抑制剂结合模式的方程。该方法在三种模型酶系统(即PK、腺苷酸激酶和LDH)中用已知抑制剂进行了评估。该方法还用于表征从包含120,000个不同化学实体的化合物库的高通量筛选中鉴定出的大量未知Csp3抑制剂,这一现场测试验证了该方法的实用性。在分析的76种Csp3抑制剂中,发现70种为非互斥性抑制剂,表明Csp3中存在用于有效抑制的变构位点。讨论了这一观察结果的意义。